Pharvaris

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pharvaris and other ETFs, options, and stocks.

About PHVS

Pharvaris NV is a clinical-stage company, which engages in bringing oral bradykinin B2-receptor antagonists to patients. It focuses on the development and commercialization of innovative therapies for rare diseases focused on angioedema and other bradykinin-mediated diseases.

CEO

Berndt A. E. Modig

CEOBerndt A. E. Modig

Employees

108

Employees108

Headquarters

Leiden, Zuid-Holland

HeadquartersLeiden, Zuid-Holland

Founded

2015

Founded2015

Employees

108

Employees108

PHVS Key Statistics

Market cap

981.42M

Market cap981.42M

Price-Earnings ratio

-5.96

Price-Earnings ratio-5.96

Dividend yield

—

Dividend yield—

Average volume

29.79K

Average volume29.79K

High today

—

High today—

Low today

—

Low today—

Open price

$19.00

Open price$19.00

Volume

0.00

Volume0.00

52 Week high

$25.50

52 Week high$25.50

52 Week low

$11.51

52 Week low$11.51

Analyst ratings

91%

of 11 ratings

Buy

90.9%

Hold

Sell

9.1%

People also own

Based on the portfolios of people who own PHVS. This list is generated using Robinhood data, and it’s not a recommendation.

Ford Motor

Palantir Technologies